Author: Zech

NEW DELHI: Building on the success of the Chandrayaan-3 mission, Finance Minister Nirmala Sitharaman on Tuesday announced a Rs 1,000 crore fund to boost space technology development. Presenting her seventh consecutive Budget, the Finance Minister said a Rs 1,000 crore venture capital fund would be set up to expand the space economy five times over the next decade and support over 180 government-recognised space technology start-ups.The announcement came following the presentation of the Economic Survey 2023-24 in Parliament on Monday. The Survey highlighted the impressive progress made in the space sector in recent years, including advancements in rockets, satellites, spacecraft…

NEW DELHI: Building on the success of the Chandrayaan-3 mission, Finance Minister Nirmala Sitharaman on Tuesday announced a Rs 1,000 crore fund to boost space technology development. Presenting her seventh consecutive Budget, the Finance Minister said a Rs 1,000 crore venture capital fund would be set up to expand the space economy five times over the next decade and support over 180 government-recognised space technology start-ups.Also see: FY24 Budget UpdateThe announcement came following the presentation of the Economic Survey 2023-24 in Parliament on Monday. The Survey highlighted the impressive progress made in the space sector in recent years, including advancements…

MAIA Biotechnology (NYSE American: MAIA) has announced positive updates from its Phase 2 THIO-101 trial, evaluating THIO sequenced with cemiplimab in advanced non-small cell lung cancer (NSCLC) patients who failed multiple standard therapies. Key highlights include:1. Six patients have continued treatment for over 12 months, completing up to 21 cycles.2. The THIO-cemiplimab combination shows significantly lower toxicity compared to standard treatments.3. Treatment longevity suggests safety, efficacy, and ongoing benefits of MAIA’s novel telomere-targeting therapy.4. Current second-line NSCLC treatments typically last 3-4 months, while THIO patients are showing much longer treatment durations.These results indicate THIO’s potential…

CHICAGO, July 23, 2024–(BUSINESS WIRE)–MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, “the Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive treatment progress in THIO-101, a Phase 2 clinical trial evaluating THIO in combination with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who have failed two or more standard treatment regimens.The treatment regimen in the trial is cycled every 3 weeks, with THIO 180 mg in 60 mg increments on days 1, 2, and 3, immune activation (no administration) on day 4, and cemiplimab 350 mg on…

Military IoT MarketThe latest study on “Military IoT Market” published by HTF MI Research evaluates the market size, trends, and forecast to 2030. The Military IoT Market study contains key research data and evidence that serves as a practical resource document for managers, analysts, industry experts, and other key players to conduct easily accessible and self-analyzed research that helps in understanding market trends, growth factors, opportunities, upcoming challenges, and competitive intelligence. Key companies profiled in the study include Cisco (US), FLIR Systems (US), AT&T (US), Forescout Technologies (US), Honeywell (US), Northrop Grumman Corp. (US), Thales (France), BAE Systems (UK), IBM…

Transportation InvestmentAerial robotics pioneer True Position Robotics has raised £1 million in its first major equity deal from the British Business Bank’s Midlands Engine Investment Fund II. TPR is a Nottingham-based company whose industrial robots have the potential to revolutionise aircraft production and significantly reduce the cost of new aircraft. The company was founded by Roger Holden in 2018 to pioneer a way to automate the aircraft assembly process using low-cost, off-the-shelf industrial robots with its own software and hardware. The company has already partnered with industry giants including BAE, which is adopting the technology as part of its ‘Factory…

New Delhi : Buoyed by the success of the Chandrayaan-3 mission, Finance Minister Nirmala Sitharaman on Tuesday announced setting up of a Rs 1,000 crore fund to boost development of space technology.The announcement was made during the 2024 Union Budget speech in the Indian Parliament and is expected to support more than 180 government-endorsed space tech startups.”We remain focused on expanding the space economy five times over the next decade and a venture capital fund of Rs 1,000 crore will be set up,” she said.The announcement came after Sitharaman, in the Economic Survey for 2023-24 tabled in Parliament on Monday,…

Tested cybersecurity solutions undergo rigorous testing to ensure they meet the standards expected in today’s challenging cyber threat landscape.”AV-Comparatives certification serves as an important benchmark in the field of cybersecurity, providing essential assurance for the protection of enterprises.” — Peter Stelzhammer, Co-Founder, AV-ComparativesINNSBRUCK, Austria, July 23, 2024 /PRNewswire/ — AV-Comparatives, a leading independent testing laboratory specializing in enterprise cybersecurity solutions, is pleased to announce the results of its latest comprehensive evaluation. For more than 20 years, the laboratory has established itself as a bastion of reliability and expertise in the cybersecurity field, earning the trust of industry experts and CISOs.…

Avail, the blockchain “data availability” project that spun out of Polygon in early 2023 and raised $75 million in funding, is finally launching.According to a press release, the project’s main network was scheduled to go live on Tuesday along with its native token, AVAIL.Data Availability (DA for short) is a specialized technology that cheaply and efficiently stores the huge amounts of transactional data generated by blockchains, such as Layer 2 networks on Ethereum. Avail joins a growing field of projects, including pioneer Celestia, that aim to capitalize on the growing demand for services as blockchain networks grow.”The launch of Avail…

PDS Biotechnology, Inc. (NASDAQ:PDSB – Get Free Report) shares rose 0.8% during trading on Monday. The company’s shares traded as high as $3.94 and closed at $3.90. 195,832 shares were traded during trading, down 75% from the average trading volume of 770,141 shares. The stock closed at $3.87 earlier. Analysts Set New Price Targets Several brokerage firms have recently commented on PDSB. B. Riley lowered their price target on PDS Biotechnology from $11.00 to $9.00 and gave the company a “buy” rating in a research report on Wednesday, June 12th. HC Wainwright reaffirmed their “buy” rating and set a $21.00…